FAQs

10. Are any risks associated with donating PBSCs?

Apheresis usually causes minimal discomfort. During apheresis, the person may feel lightheadedness, chills, numbness around the lips, and cramping in the hands. Unlike bone marrow donation, PBSC donation does not require anesthesia. The medication that is given to stimulate the release of stem cells from the marrow into the bloodstream may cause bone and muscle [...]

By |2018-02-26T08:17:12+03:00July 16th, 2017||0 Comments

9. Are any risks associated with donating bone marrow?

Because only a small amount of bone marrow is removed, donating usually does not pose any significant problems for the donor. The most serious risk associated with donating bone marrow involves the use of anesthesia during the procedure. The area where the bone marrow was taken out may feel stiff or sore for a few [...]

By |2018-02-26T08:16:19+03:00July 16th, 2017||0 Comments

7. How are PBSCs obtained for transplantation?

The stem cells used in PBSCT come from the bloodstream. A process called apheresis or leukapheresis is used to obtain PBSCs for transplantation. For 4 or 5 days before apheresis, the donor may be given a medication to increase the number of stem cells released into the bloodstream. In apheresis, blood is removed through a [...]

By |2018-02-26T08:15:17+03:00July 16th, 2017||0 Comments

6. How is bone marrow obtained for transplantation?

The stem cells used in BMT come from the liquid center of the bone, called the marrow. In general, the procedure for obtaining bone marrow, which is called “harvesting,” is similar for all three types of BMTs (autologous, syngeneic, and allogeneic). The donor is given either general anesthesia, which puts the person to sleep during [...]

By |2018-02-26T08:14:53+03:00July 16th, 2017||0 Comments

5. How are the donor’s stem cells matched to the patient’s stem cells in allogeneic transplantation?

To minimize potential side effects, doctors most often use transplanted stem cells that match the patient’s own stem cells as closely as possible. People have different sets of proteins, called human leukocyte-associated (HLA) antigens, on the surface of their cells. The set of proteins, called the HLA type, is identified by a special blood test. [...]

By |2018-02-26T08:13:26+03:00July 16th, 2017||0 Comments

4. What types of cancer are treated with BMT and PBSCT?

BMT and PBSCT are most commonly used in the treatment of leukemia and lymphoma. They are most effective when the leukemia or lymphoma is in remission (the signs and symptoms of cancer have disappeared). BMT and PBSCT are also used to treat other cancers such as neuroblastoma (cancer that arises in immature nerve cells and [...]

By |2018-02-26T08:12:52+03:00July 16th, 2017||0 Comments

3. Why are BMT and PBSCT used in cancer treatment?

One reason BMT and PBSCT are used in cancer treatment is to make it possible for patients to receive very high doses of chemotherapy and/or radiation therapy. To understand more about why BMT and PBSCT are used, it is helpful to understand how chemotherapy and radiation therapy work. Chemotherapy and radiation therapy generally affect cells [...]

By |2018-02-26T08:09:20+03:00July 16th, 2017||0 Comments

2. What are bone marrow transplantation and peripheral blood stem cell transplantation?

Bone marrow transplantation (BMT) and peripheral blood stem cell transplantation (PBSCT) are procedures that restore stem cells that have been destroyed by high doses of chemotherapy and/or radiation therapy. There are three types of transplants: In autologous transplants, patients receive their own stem cells. In allogeneic transplants, patients receive stem cells from their brother, sister, or parent. [...]

By |2018-02-26T08:08:30+03:00July 16th, 2017||0 Comments
Go to Top